Studying immune cells from blood and spinal fluid in multiple sclerosis
Examines immune cell types from blood and spinal fluid in adults with multiple sclerosis.
Plain-language title generated from the registry record
Registry title: Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
Key facts
- Where
- Bordeaux, FranceSee the site
Where in France
- CHU de Bordeaux - service de neurologieBordeaux, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Bordeaux
- Trial code
- NCT04798651
- Record updated
- 26 October 2026
- Original description
The study aims at identifying the type of B and CD4 T cell subsets with pathogenic properties in the different clinical forms of multiple sclerosis. This research might open new therapeutic approaches for the treatment of multiple sclerosis particularly progressive MS.Read full original descriptionShow less
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
The study aims at identifying the type of B and CD4 T cell subsets with pathogenic properties in the different clinical forms of multiple sclerosis. This research might open new therapeutic approaches for the treatment of multiple sclerosis particularly progressive MS.
Inclusion: male or female subjects ; Age ≥ 18 years; subjects with MS defined by 2010 revised McDonald criteria or presenting a clinical isolated syndrome; patients for which a blood draw and / or lumbar puncture to collect CSF is performed for diagnostic or therapeutic purpose; affiliated to an health insurance system; and who agree to participate in the study.
Exclusion: patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent); Pregnant or breastfeeding women,.